Vogue Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 20 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.77 M
as on 16-11-2024
- Revenue 57.19%
(FY 2023)
- Profit -283.12%
(FY 2023)
- Ebitda 194.80%
(FY 2023)
- Net Worth -18.95%
(FY 2023)
- Total Assets 19.05%
(FY 2023)
About Vogue Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.77 M.
Shubham Agarwal and Raju Agrawal serve as directors at the Company.
- CIN/LLPIN
U51397DL2004PTC127270
- Company No.
127270
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jun 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Vogue Pharmaceuticals Private Limited offer?
Vogue Pharmaceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Vitamin Tablets & Capsules, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Digestive System Drugs & Medicines, Pre & Probiotic Capsule, Fitness Supplements, Organic and Inorganic Solvents, Ketones.
Who are the key members and board of directors at Vogue Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shubham Agarwal  | Director | 12-Mar-2015 | Current |
| Raju Agrawal | Director | 30-Jun-2004 | Current |
Financial Performance of Vogue Pharmaceuticals.
Vogue Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 57.19% increase. The company also saw a substantial fall in profitability, with a 283.12% decrease in profit. The company's net worth observed a substantial decline by a decrease of 18.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vogue Pharmaceuticals?
In 2023, Vogue Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 05 Apr 2024 | ₹3.62 M | Open |
Hdfc Bank Limited Creation Date: 16 Oct 2023 | ₹1.65 M | Open |
Hdfc Bank Limited Creation Date: 24 Mar 2022 | ₹2.50 M | Open |
How Many Employees Work at Vogue Pharmaceuticals?
Vogue Pharmaceuticals has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vogue Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vogue Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
